periplogenin has been researched along with d-alpha tocopherol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kar, A; Panda, S | 1 |
| Guo, L; Huang, Z; Liang, G; Meng, C; Su, W; Wei, X; Wei, Y; Ye, H | 1 |
2 other study(ies) available for periplogenin and d-alpha tocopherol
| Article | Year |
|---|---|
Periplogenin-3-O- -D-glucopyranosyl -(1-->6)- -D-glucopyaranosyl- -(1-->4) -D-cymaropyranoside, isolated from Aegle marmelos protects doxorubicin induced cardiovascular problems and hepatotoxicity in rats.
Topics: Aegle; Alanine Transaminase; alpha-Tocopherol; Animals; Antibiotics, Antineoplastic; Antioxidants; Body Weight; Cardiovascular Diseases; Catalase; Chemical and Drug Induced Liver Injury; Creatine Kinase, MB Form; Digitoxigenin; Disease Models, Animal; Dose-Response Relationship, Drug; Doxorubicin; Glutathione; Lipid Peroxidation; Lipids; Liver Diseases; Plant Leaves; Rats; Rats, Wistar; Superoxide Dismutase | 2009 |
Mechanism of Action of Periplogenin on Nasopharyngeal Carcinoma Based on Network Pharmacology and Experimental Study of Vitamin E Coupled with Periplogenin Self-Assembled Nano-Prodrug for Nasopharyngeal Carcinoma.
Topics: Digitoxigenin; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Phosphatidylinositol 3-Kinases; Prodrugs; Vitamin E | 2020 |